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INTRODUCTION 
Solubilisation of poorly soluble drugs is a frequently 
encountered challenge in screening studies of new 
chemical entities as well as in formulation design and 
development. If any drug has very less solubility, then 
therapeutic effectiveness of that drug will be lesser 
because of very less systemic availability of it. 
Bioavailability is defined as the rate and extent to 
which the active drug is absorbed from a dosage form 
and becomes available at the site of drug action. 
Bioavailability depends on drug solubility in an 
aqueous environment and drug permeability through 
lipophilic membranes1.This is a well-known fact that 
only solubilized drug molecules can be absorbed by the 
cellular membranes to subsequently reach the site of 
drug action (vascular system for instance). A drug can 
be defined bioavailable if it belongs to the class I (high 
solubility and high permeability) of Biopharmaceutical 
Classification System (BCS). Poorly soluble 
compounds belong to class II of the (BCS). It is 
difficult to develop a new molecule with good 
pharmacological activity having desired solubility and 
permeability. It has been reported that about 40% of 
the compounds being developed by the pharmaceutical 
industries are poorly water soluble out of which up to 
40% of pharmacologically active new molecules failed 
to reach the market only due to little or no water 
solubility. Today pharmaceutical companies have been 
able to overcome difficulties with very slightly soluble 
drugs, those with aqueous solubility of less than 0.1 
mg/ml present some unique challenges. These drugs 
are particularly good candidates for advanced 
solubilisation technologies developed by companies 
specializing in drug delivery2.From Noyes Whitney 
equation, possibilities for improving drug dissolution 
are to increase the surface area of drug available for 
dissolution by decreasing the particle size of the solid 
compound and/or by optimizing the wetting 
characteristics of the compound surface3. Therefore, 
various formulation strategies have been investigated 
to improve solubility and dissolution rate of poorly 
water soluble drugs such as inclusion complexation 
with cyclodextrins, solid dispersion, salt formation, 
particle size reduction, use of surfactants, co-solvency, 
hydrotropy etc4.  
TECHNIQUES OF SOLUBILITY 
ENHANCEMENT
5, 6 
1. Chemical Modifications 
2. Physical Modifications 
 Particle size reduction:  
I. Micronization 
II. Nanosuspension 
 Modification of the crystal habit: 
I. Polymorphs 
II. Pseudo polymorphs 
 Drug dispersion in carriers: 
I. Eutectic mixtures 
II. Solid dispersions 
III. Solid solutions 
 Complexation 
I. Complexing agents 
 Solubilisation by surfactants 
II. Micro emulsions 
ABSTRACT 
The goal of the present investigation is formulation and evaluation of a mucoadhesive gel for buccal delivery after solubility 
enhancement of very slightly water-soluble drug Miconazole Nitrate. Miconazole Nitrate is imidazole derivative useful in 
treatment of oropharyngeal Candidiasis, the most common infection in AIDS patients. The method namely solvent deposition 
with inclusion complex, solid dispersion with inclusion complex and solvent deposition with solid dispersion are used for 
solubility enhancement. Various polymers such as Lactose, β-CD and PEG-6000 are those polymers which were used for 
individual methods like SolD, IC and SD respectively all the batches are evaluated for their water solubility and In-vitro 
release. Enhancement of dissolution rates with increasing quantity of β-CD, Lactose and PEG in the complexes is observed. 
Water solubility of Miconazole Nitrate is enhanced up to 321.9 times by using combination of methods (solvent deposition 
with inclusion complex) and mucoadhesive antifungal gel of Miconazole Nitrate is prepared with improved drug release in to 
the buccal cavity which ensures effective treatment of local fungal infection-Oropharyngeal Candidiasis. 
Keywords: Mucoadhesive, dissolution rate, solubility enhancement. 
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III. Self-micro emulsifying system 
 
CHEMICAL MODIFICATIONS 
7,8
 
Salt Formation: 
It is the most common and effective method of 
increasing solubility and dissolution rates of acidic and 
basic drugs. Example of acidic or basic drug which is 
converted into salts has more solubility than that of 
respective drug like aspirin, theophylline, barbiturates 
etc. 
Co-crystallisation: 
Anew approach available for the enhancement of drug 
solubility is through the application of the co-crystals, 
it is also referred as molecular complexes. Co-crystals 
may be defined as crystalline material that consist of 
two or more molecular (electrical neutral) species held 
together by non-covalent forces. It can be prepared by 
evaporation of a heteromeric solution or by grinding 
the components together or by sublimation, growth 
from the melt slurry preparation. It is increasingly 
important as an alternative to salt formation, 
particularly for neutral compounds. 
Co-solvency: 
It is well-known that the addition of an organic co-
solvent to water can dramatically change the solubility 
of drugs. Weak electrolytes and nonpolar molecules 
have poor water solubility and it can be improved by 
altering polarity of the solvent. The solvent used to 
increase solubility is known as co-solvent. It is 
commonly referred to as solvent blending. 
Hydrotropy: 
It designates to increase in solubility in water due to 
presence of large amount of additives. It improves 
solubility by complexation involving weak interaction 
between hydrophobic agents (Sodium benzoate, 
sodium alginate, and urea) and solute e.g.sublimation 
of theophylline with sodium acetate and sodium 
alginate. 
Solubilising Agents: 
The solubility of poorly soluble drug can also be 
improved by various solubilising materials. PEG 400 
improves the solubility of hydrochlorothiazide. 
Nanotechnology Approaches 
Nanotechnology can be used to improve drugs that 
currently have poor solubility. Nanotechnology refers 
broadly to the study and use of materials and structures 
at the nanoscale level of approximately 100 nanometre 
(nm) or less. For many new chemical entities of very 
low solubility, oral bioavailability enhancement by 
micronisation is not sufficient because micronized 
product has very low effective surface area for 
dissolution and next step taken was nanonisation. 
PHYSICAL MODIFICATIONS
7, 9
 
Particle Size Reduction: 
The techniques of size reduction using various milling 
processes are well established and these practices are a 
standard part of formulation development. This can be 
done mainly by micronisation &Nano suspension.  As 
particle size decreases, surface area of particle 
increases resulting in increase in solubility. 
Sonocrystallisation technique is also used for particle 
size reduction.  
Modification of Crystal Habit:  
Polymorphism is the ability of an element or 
compound to crystallize in more than one crystalline 
form. Different polymorphs of drugs are chemically 
identical, but they exhibit different physicochemical 
properties including solubility, melting point, density, 
texture, stability etc. Similarly amorphous form of drug 
is always more suited than crystalline form due to 
higher energy associated and increase in surface area. 
Order for dissolution of different solid forms of drug, 
are- 
Amorphous >Metastable polymorph >Stable 
polymorph. 
Complexation: 
Complexation is the association between two or more 
molecules to form a non bonded entity with a well-
defined stoichiometry. Complexation relies on 
relatively weak forces such as London forces, 
hydrogen bonding and hydrophobic interactions. 
Examples of complexing agents are; chelates- EDTA, 
EGTA, molecular complexes- polymers and inclusion 
complexes cyclodextrins. 
Solubilisation by Surfactants: 
Surfactants are molecules with distinct polar and 
nonpolar regions. Most surfactants consist of a 
hydrocarbon segment connected to a polar group. The 
polar group can be anionic, cationic, zwitterionic or 
non-ionic. When small polar molecules are added they 
can accumulate in the hydrophobic core of the 
micelles. This process of solubilisation is very 
important in industrial and biological processes. The 
presence of surfactants may lower the surface tension 
but increases solubility of drug.  Although salt 
formation, particle size reduction, etc. have commonly 
been used to increase dissolution rate of the drug, there 
are practical limitation with these techniques the 
desired bioavailability enhancement may not always be 
achieved. Therefore formulation approaches are being 
explored to enhance bioavailability of poorly water-
soluble drugs. One such formulation approach that has 
been shown to significantly enhance absorption of such 
drugs is to formulate solid dispersion. Solid dispersion 
of an amorphous drug in a polymer matrix has been 
demonstrated to be an effective tool for solubility and 
subsequently,bioavailability enhancement.  
Temperature 
Generally, an increase in the temperature of the 
solution increases the solubility of a solid solute. For 
gaseous solutes, an increase in pressure increases 
solubility and a decrease in pressure decrease the 
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solubility. For solids and liquid solutes, change in 
pressure has practically no effect on solubility.  
Nature of the Solute and Solvent 
Only 1 gram of lead (II) chloride can be dissolved in 
100 gram of water at room temperature while 200 gram 
of zinc chloride can be dissolved within same volume 
of water. The difference in the solubility of these two 
substances is the result of differences in their nature.  
Molecular Size 
Larger the molecule or higher molecular weight 
ensures less solubility of the substance. In case of 
organic compounds the amount of carbon branching 
will increase the solubility since more branching will 
reduce the size (or volume) of the molecule and make 
it easier to solvate the molecules with solvent. 
Polarity 
Polarity of the solute and solvent molecules affect the 
solubility. Generally non-polar solute molecules 
dissolve in non-polar solvents and polar solute 
molecules dissolve in polar solvents. The polar solute 
molecules have a positive and a negative end to the 
molecule. If the solvent molecules are polar then 
positive end of solvent molecules attract negative end 
of solute molecules. This is a type of intermolecular 
force known as dipole-dipole interaction. Molecules 
also have a type of intermolecular force much weaker 
than the other forces called London Dispersion forces 
where the positive nuclei of the atoms of the solute 
molecule will attract the negative electrons of the 
atoms of a solvent molecule. This gives the non-polar 
solvent a chance to solvate the solute molecules.  
Polymorphs 
The capacity for a substance to crystallize in more than 
one crystalline form is polymorphism. If the change 
from one polymorph to another is reversible, the 
process is called enantiotropic. If the system is 
monotropic, there is a transition point above the 
melting points of both polymorphs. Polymorphs can 
vary in melting point. Since the melting point of the 
solid is related to solubility, so polymorphs show 
different solubility. Generally the range of solubility 
between different polymorphs is only 2-3 folds due to 
relatively small differences in free energy.  
Rate of Solubilization 
The rate of solubilization is a measure of how fast 
substances dissolve in solvents. 
Rate of Solubilization 
The rate of solubilization is a measure of how fast 
substances dissolve in solvents. 
Methods of Choice  
Particle Size Reduction: Melt-sonocrystallisation 
Particle engineering techniques are being developed to 
modify the physicochemical, micromeritic and 
biopharmaceutical properties of the drug. Numbers of 
particle design techniques is reported, such as spherical 
crystallization, extrusion spheronization, melt 
solidification, spray drying, pastillation, solution 
atomization and crystallization by sonication (SAXS), 
where simultaneous crystallization and agglomeration 
occur. It is used to enhance dissolution of hydrophobic 
drugs and to study its effect on crystal properties of 
drug. It forms drug agglomerates with number of 
shallow circular pits on the surface and leads to 
increase in solubility. The effect of application of US 
energy on the properties of melt sonocrystallized 
(MSC) valdecoxib was characterized by scanning 
electron microscopy (SEM), differential scanning 
calorimetery (DSC), X-ray powder diffraction (XRPD), 
infrared spectroscopy and saturated solubility studies.
 
PROCEDURE:    
Melting of drug in a vessel on an oil bath 
 
Molten mass is poured in a vessel containing deionized water 
 
Sonication for some time using probe ultrasonicator 
 
Collection of the product after solicitation of dispersed droplet by filtration 
 
Drying at room temperature 
 
Solubility studies 
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Solid Dispersions: 
The term solid dispersion refers to a group of solid 
products consisting of at least two different 
components, generally a hydrophilic matrix and a 
hydrophobic drug; the matrix can be either crystalline 
or amorphous.  
Carriers for Solid Dispersions: 
The solubility of etoposide, glyburide, itraconazole, 
ampelopsin, valdecoxib, celecoxib, halofantrine can be 
improved by solid dispersion using suitable hydrophilic 
carriers.
 
Table 1:  Example of Carriers
7
 
Sr. No. Chemical Class Examples 
1 Acids Citric acid, Tartaric acid, Succinic acid 
2 Sugars Dextrose, Sorbitol, Sucrose, Maltose, Galactose, Xylitol 
3 
Polymeric Materials 
Polyvinylpyrrolidone, PEG-4000, PEG-6000, Carboxymethyl cellulose, 
Hydroxypropyl cellulose, Sodium alginate 
4 Surfactants Polyoxyethylene stearate, Poloxamer, Deoxycholic acid, Tweens and Spans 
 
ADVANTAGES OF SOLID DISPERSIONS
 8
,
9
 
Particle Size 
Molecular dispersions, as solid dispersions, represent 
the last state on particle size reduction and after carrier 
dissolution the drug is molecularly dispersed in the 
dissolution medium. Solid dispersions apply this 
principle to drug release by creating a mixture of a 
poorly water soluble drug and highly soluble carriers. 
Wettability 
A strong contribution to the enhancement of drug 
solubility is related to the drugwettability improvement 
verified in solid dispersions. It was observed thateven 
carriers without any surface activity, such as urea 
improved drug wettability. Carriers with surface 
activity such as cholic acid and bile salts when used 
can significantly increase the wettability property of 
drug. Moreover, carriers’ caninfluence the drug 
dissolution profile by direct dissolution or co-solvent 
effects.  
Porosity 
Particles in solid dispersions have been found to have a 
higher degree of porosity. The increase in porosity also 
depends on the carrier properties; for instance, solid 
dispersions containing linear polymers produce larger 
and more porous particles than those containing 
reticular polymers and therefore, result in a higher 
dissolution rate.  The increased porosity of solid 
dispersion particles also hastens the drug release 
profile. 
Amorphous State 
Poorly water soluble crystalline drugs, when in the 
amorphous state tend to have higher solubility. The 
enhancement of drug release can usually be achieved 
using the drug in its amorphous state, because no 
energy is required to break up the crystal lattice during 
the dissolution process In solid dispersions, drugs are 
presented as supersaturated solutions after dissolution 
and it is speculated that, if drugs precipitate, it is as a 
metastable polymorphic form with higher solubility 
than the most stable crystal form. For drugs with low 
crystal energy (low melting temperature or heat of 
fusion), the amorphous composition is primarily 
dictated by the difference in melting temperature 
between drug and carrier. For drugs with high crystal 
energy, higher amorphous compositions can be 
obtained by selecting carriers, which exhibit specific 
interactions with them. 
DISADVANTAGES OF SOLID DISPERSION 
METHOD
9, 11
 
The limitations solid dispersions include: 
1. Laborious and expensive method of 
preparation 
2. Reproducibility of physicochemical 
characteristics 
3. Difficulty in incorporating into formulation 
4. Scale-up of manufacturing process 
5. Stability of the drug and vehicle 
Carrier and Solvent Selection 
Carrier and solvent selection is influenced by the 
chemistry of the drug. It should optimize solubility of 
the drug in the carrier. 
Carrier Selection: 
 1st Generation:Crystalline carriers like urea, sugar 
and organic acid 
 2nd Generation:Amorphous carriers like PEG, 
PVA, povidone and cellulose derivatives 
 3rd Generation:Surface active self-emulsifying 
carriers like poloxamer 407, tween 80, gelucire 
44/14, compritol 888 ATO +/- polymer 
Preparation of Solid Dispersions  
     Various preparation methods for solid dispersions 
have been reported: 
1. Fusion method 
2. Solvent Evaporation Method 
3. Melt agglomeration 
4. Surface-active Carriers 
5.  
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CHARACTERIZATION OF SOLID DISPERSION
9, 10
 
Table 2: Characterization of Solid Dispersions 
S. No. Characterization Methods Significance 
1 
Drug-carrier 
Miscibility 
Hot stage microscopy DSC (conventional 
modulated) pXRD (conventional and variable 
temp), NMR 1H spin lattice relaxation time 
To find out the complex formation 
between drug and carrier. 
2 
Drug-carrier 
interactions 
FT-IR spectroscopy, Raman spectroscopy and Solid 
state NMR studies 
To find out the integration between 
drug and carrier and formation of 
inclusion complex. 
3 Physical structure SEM Surface area analysis To find out the particle size and shape. 
4 Surface properties 
Dynamic vapour sorption, 
Inverse gas chromatography, 
Atomic force microscopy and 
Raman microscopy 
To study the morphology and degree to 
study the morphology and degree of 
crystallinity. 
5 
Amorphous 
content 
Polarized light optical microscopy Hot stage 
microscopy, Humidity stage microscopy, DSC 
(MTDSC), ITC, Pxrd 
To find out the amorphous form of 
drug. 
6 
Stability 
 
Humidity studies Isothermal Calorimetry DSC (Tg, 
temperature recrystallisation) Dynamic vapour 
sorption Saturated solubility studies 
To find out the degree of crystallinity 
7 
Dissolution 
enhancement 
 
Dissolution, Intrinsic dissolution, Dynamic 
solubility and Dissolution in bio-relevant media 
To find out the rate and extent of  
dissolution 
 
 
Application of Solid Dispersion in Pharmaceutical 
Industries:
 9, 10, 11, 12
 
The application of solid dispersions for increasing drug 
bioavailability is by no means a new field of 
pharmaceutical research.  Different applications are 
enlisted below- 
● Increases oral bioavailability of poorly water-
soluble drugs. 
● Suitable for oral delivery. 
● No change in chemical properties of the drug. 
● Relatively simple processing techniques. 
● Uses conventional equipment’s. 
● Increases dissolution due to metastable solid state 
apart from absorption   enhancement, the solid 
dispersion technique may have numerous 
pharmaceutical applications, which should be 
further explored.  
● To obtain a homogeneous distribution of a small 
amount of drug in solid state. 
● To stabilize the unstable drug. 
● To dispense liquid (up to 10%) or gaseous 
compounds in a solid dosage. 
● To formulate a fast release primary dose in a 
sustained released dosage form. 
● To formulate sustained release regimen of soluble 
drugs by using poorly soluble or insoluble carriers. 
● To reduce pre systemic inactivation of drugs like 
morphine and progesterone. 
●  Polymorphs in a given system can be converted 
into isomorphous, solid solution, eutectic or 
molecular addition compound. 
Complexation: 
Complexation is the association between two or more 
molecules to form a no bonded entity with a well-
defined stoichiometry. Complexation relies on 
relatively weak forces such as London forces, 
hydrogen bonding and hydrophobic interactions.  
LIST OF COMPLEXING AGENTS
13, 14 
Table 3: Examples of Complexing Agents 
S. 
N. 
Types Examples 
1 Inorganic Iodide (I-) 
2 Coordination Hexamine cobalt(III) 
chloride 
3 Chelates EDTA, EGTA 
4 Metal-Olefin Ferrocene 
5 Inclusion Cyclodextrins, Choleic acid 
6 Molecular Complexes Polymers 
 
Solvent Deposition Method: 
The principle of solvent deposition technique is 
deposition of the drug in “minuscular form” from an 
organic solvent on to the surface of an inert excipient. 
Due to micronization the surface area of drug increases 
which in turn improves dissolution rate. Drug solvent 
deposition system (SDS) was prepared by adsorbing 
drug over lactose particles14,15 
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Procedure 
1. Proportions of drug: lactose. 
2. Required amount of drug powder is dissolved in 
organic solvent to form a clear solution. 
3. A known amount of lactose is dispersed in the 
drug solution. 
4. The solvent is evaporated at room temperature 
with constant stirring. 
5. Products thus obtained are kept in vacuum oven at 
37 °C for 24 hrs to allow complete evaporation of 
organic solvent. 
6. The SDS thus formed is passed through 60-mesh 
sieve to get dry free flowing powder. 
7. Fraction of drug powder is used for saturated 
solubility study16, 17, and 18. 
 
CURRENT & FUTURE DEVELOPMENTS 
Currently only 8% of new drug candidates have both 
high solubility and permeability. Because of solubility 
problems of many drugs their bioavailability gets 
affected and hence solubility enhancement becomes 
necessary. It is possible to increase the solubility of 
poorly water soluble drugs with the help of various 
techniques as mentioned above. All the above methods 
are applicable not only to molecules of a specific 
physical and chemical nature, but to a wide range of 
crystalline materials, although a comprehensive 
knowledge of drugs at the molecular level is required 
to determine the appropriate approach to improve 
solubility and dissolution rate. A probable candidate 
for solubility enhancement could be Miconazole 
Nitrate since it belongs to BCS class II. It is a popular 
drug of choice for treatment of local fungal infections. 
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